Purpose: To present a single-center experience on pituitary tumor apoplexy and a review of literature focusing on predisposing and precipitating factors. Methods: Clinical presentation of our series of cases. Contemporary published literature is also reviewed. Results: The definition of this syndrome has not been consistent although now the majority of authors agree to definite it as an acute condition caused by hemorrhage or infarction of a pre-existing pituitary adenoma. Different predisposing and precipitating factors have been described in literature; among these antithrombotic and anticoagulant drugs, seem to play relevant roles. The clinical cases observed in our clinic confirm these data and suggest a probable association between elderly patients taking anticoagulant therapy and pituitary apoplexy adenoma. Conclusion: Pituitary tumor apoplexy remains a challenging disease in relation to difficulties in correct diagnosis and thus in appropriate treatment. Antithrombotic/anticoagulant therapy may have an important role as precipitating factor. When a pituitary disorder is known, great care should be taken in the prescription of anticoagulant therapy.

Giammattei, L., Mantovani, G., Carrabba, G., Ferrero, S., Di Cristofori, A., Verrua, E., et al. (2016). Pituitary apoplexy : considerations on a single center experience and review of the literature. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 39(7), 739-746 [10.1007/s40618-015-0424-2].

Pituitary apoplexy : considerations on a single center experience and review of the literature

G. Carrabba;A. Di Cristofori;
2016

Abstract

Purpose: To present a single-center experience on pituitary tumor apoplexy and a review of literature focusing on predisposing and precipitating factors. Methods: Clinical presentation of our series of cases. Contemporary published literature is also reviewed. Results: The definition of this syndrome has not been consistent although now the majority of authors agree to definite it as an acute condition caused by hemorrhage or infarction of a pre-existing pituitary adenoma. Different predisposing and precipitating factors have been described in literature; among these antithrombotic and anticoagulant drugs, seem to play relevant roles. The clinical cases observed in our clinic confirm these data and suggest a probable association between elderly patients taking anticoagulant therapy and pituitary apoplexy adenoma. Conclusion: Pituitary tumor apoplexy remains a challenging disease in relation to difficulties in correct diagnosis and thus in appropriate treatment. Antithrombotic/anticoagulant therapy may have an important role as precipitating factor. When a pituitary disorder is known, great care should be taken in the prescription of anticoagulant therapy.
Articolo in rivista - Articolo scientifico
anticoagulant therapy; apoplexy; pituitary; review; endocrinology; diabetes and metabolism; endocrinology
English
2016
39
7
739
746
reserved
Giammattei, L., Mantovani, G., Carrabba, G., Ferrero, S., Di Cristofori, A., Verrua, E., et al. (2016). Pituitary apoplexy : considerations on a single center experience and review of the literature. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 39(7), 739-746 [10.1007/s40618-015-0424-2].
File in questo prodotto:
File Dimensione Formato  
Gianmattei JEI.pdf

Solo gestori archivio

Dimensione 460.62 kB
Formato Adobe PDF
460.62 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/329445
Citazioni
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 12
Social impact